SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 23, 2002 (August 16, 2002)
----------------------------------
Introgen Therapeutics, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-21291 74-2704230
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
301 Congress Avenue, Suite 1850, Austin, Texas 78701
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (512) 708-9310
-----------------------------
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS.
On August 16, 2002, Elise Wang resigned from the Board of Directors of
Introgen Therapeutics, Inc. (the "Company"). Ms. Wang had served as a director
of the Company since January 2001, and had also served as a member of the Audit
Committee of the Board of Directors during that period. The Company issued a
press release on August 23, 2002 regarding this matter, which is filed as
Exhibit 99.1 to this Current Report on Form 8-K. The contents of such Exhibit
are incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
99.1 Press Release dated August 23, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: August 23, 2002 INTROGEN THERAPEUTICS, INC.
/s/ THOMAS G. FINNEGAN
--------------------------------------
Thomas G. Finnegan, Vice President
-2-
INDEX TO EXHIBITS
Exhibit
Number Description of Document
------- -----------------------
99.1 Press Release dated August 23, 2002.